Will DOJ’s Renewed Focus On Antitrust Turn To Sentara?
2021-07-29
As Bacon’s Rebellion’s Sherlock Reports, Hampton Roads $6B health care conglomerate’s actions suggest it’s concerned about antitrust issues Those familiar with our reporting on Sentara Healthcare know we’ve raised issues about potential antitrust problems, particularly with Sentara’s aborted, $11.5 billion merger with North Carolina’s Cone Health. Now, thanks to James Sherlock of Bacon’s Rebellion, we… Read more »
Read more
Sentara’s Whine About Unfair Coverage
2021-07-16
As Checks and Balances Project reported on the business practices of Sentara Healthcare, we sought comment from the company’s top spokesperson — Danya Bushey – more than 20 times, so we could get the company’s version of events. Bushey rarely responded. But in recent stories in the Washington Post and Virginian-Pilot, as well as a… Read more »
Read more
uninsured patients
Wall Street Journal Report Echoes C&BP Findings About Uninsured Patients
2021-07-7
In May, Checks and Balances Project showed that Sentara Healthcare makes IRS-required policies difficult to access, understand and use At least one uninsured patient was significantly overcharged Until Jan. 1, it was virtually impossible for the public to determine how much hospitals charged patients and insurance companies for the care they provided. Then an executive… Read more »
Read more